Second- and Third-Tier Therapies for Severe Traumatic Brain Injury

Area of Science:

• Neuroscience
• Critical Care Medicine
• Trauma Surgery

Background:

• Intracranial hypertension is a frequent complication in severe traumatic brain injury (TBI).
• Management requires intensive care unit (ICU) admission with intracranial pressure (ICP) monitoring.
• Multimodal neuromonitoring is recommended when feasible.

Purpose of the Study:

• To review the rationale behind the tiered therapeutic approach for intracranial hypertension in severe TBI.
• To analyze the benefits and risks associated with each tier of therapy.
• To discuss the adaptation of these recommendations for low- and middle-income countries (LMICs).

Main Methods:

• Literature review of current recommendations and therapeutic modalities for intracranial hypertension.
• Analysis of evidence regarding the efficacy, side effects, and resource implications of different treatments.
• Synthesis of findings to propose adaptations for resource-limited settings.

Main Results:

• A three-tier therapeutic strategy is standard, with escalating side effect profiles.
• Each therapeutic level offers specific benefits but carries potential risks.
• Adaptations are necessary to implement effective ICP management in LMICs.

Conclusions:

• The tiered approach to managing intracranial hypertension in severe TBI is evidence-based.
• Careful consideration of benefits, risks, and resource availability is crucial for optimal patient outcomes.
• Tailoring management strategies is essential for global application in TBI care.